[Medical therapy of obliterating arteriopathies].
D001162:Arteriosclerosis Obliterans / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy*; D005734:Gangrene / Q000188:drug therapy*; D006801:Humans; D007294:Inositol / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use*; D013919:Thromboangiitis Obliterans / Q000188:drug therapy*; D014652:Vascular Diseases / Q000188:drug therapy*; D014810:Vitamin E / Q000627:therapeutic use*
D014810:Vitamin E; D009536:Niacinamide; D007294:Inositol; D011736:Pyridoxine
Terapia medica delle arteriopatie obliteranti.